In May 2024, the Pan American Health Organization issued alerts of increased numbers of cases of Oropouche fever in non-Amazonian regions in Latin America. Following this, an association between Oropouche fever and Guillain-Barré syndrome was reported in three patients in Santiago de Cuba, Cuba. Neurological manifestations have rarely been described in relation to Oropouche virus infection. Previously, encephalitis and meningoencephalitis have been associated with Oropouche virus infection, but now the virus seems also to be associated with Guillain-Barré syndrome. In this article we describe the main factors that could underlie the increased incidence of Oropouche fever and its neurological complications. Oropouche virus should be recognized as a potential pathogen in cases of fever associated with neurological symptoms (meningitis, meningoencephalitis, and Guillain-Barré syndrome). Medical professionals and health systems need to be aware of these complications and the importance of early diagnosis and preparedness, especially during large outbreaks or in patients living in or coming from endemic regions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11836908 | PMC |
http://dx.doi.org/10.26633/RPSP.2025.23 | DOI Listing |
During May-December 2024, we detected Oropouche virus (OROV) in 13.9% (263/1,890) of febrile patients in Ceará state, Brazil. Genomic sequencing revealed those cases were caused by a novel OROV reassortant previously identified in the Amazon region.
View Article and Find Full Text PDFClin Chem
March 2025
Department of Laboratory Medicine and Pathology, Division of Clinical Microbiology, Mayo Clinic, Rochester, MN, United States.
In 2024, a novel recombinant of the Oropouche virus emerged as a potential threat. This virus has caused a significant outbreak in Brazil and Cuba, with imported cases subsequently reported in the USA and Europe. This review summarises the existing knowledge on the Oropouche virus, and discusses potential risk mitigation strategies for the transfusion community.
View Article and Find Full Text PDFCMAJ
March 2025
Department of Medicine (Dinh, Kanji, Vaughan), Cumming School of Medicine, University of Calgary and Alberta Health Services; Provincial Public Health Laboratory (Kanji), Alberta Health Services; Calvin, Phoebe, and Joan Snyder Institute for Chronic Diseases (Vaughan), University of Calgary and Alberta Health Services, Calgary, Alta.
We describe introduction of the 2022-2023 Oropouche virus lineage from Brazil, which has caused large-scale outbreaks throughout Brazil, into the Amazon Region of Peru. This lineage is co-circulating with another lineage that was circulating previously. Our findings highlight the need for continued surveillance to monitor Oropouche virus in Peru.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!